Log in
Enquire now
‌

US Patent 7655257 Sustained delivery of an active agent using an implantable system

Patent 7655257 was granted and assigned to Intarcia Therapeutics on February, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Intarcia Therapeutics
Intarcia Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7655257
Date of Patent
February 2, 2010
Patent Application Number
10645293
Date Filed
August 20, 2003
Patent Citations Received
‌
US Patent 11654183 Methods comprising continuous administration of exenatide and co-administration of a drug
0
0
‌
US Patent 11883620 Controlled flow drug delivery implantable device
0
‌
US Patent 11840559 Glucagon-receptor selective polypeptides and methods of use thereof
0
Patent Primary Examiner
‌
Michael G. Hartley
Patent abstract

The invention is directed to a device for delivering an active agent formulation for a predetermined administration period. An impermeable reservoir is divided into a water-swellable agent chamber and an active agent formulation chamber. Fluid from the environment is imbibed through a semipermeable plug into the water-swellable agent chamber and the active agent formulation is released through a back-diffusion regulating outlet. Delivery periods of up to 2 years are achieved.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7655257 Sustained delivery of an active agent using an implantable system

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.